PROPHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PROPHARMA
Largest movements
- Cash -€291,853
down €291,853 (-59.9%), from €487,211 to €195,358
mainly Contributions, distributions and other (-€204,039) and Investment in fixed assets (net) (-€93,961)
- Tangible fixed assets +€38,587
up €38,587 (+18.6%), from €207,327 to €245,914
of which Furniture and vehicles: +€36,844
- Receivables within one year +€35,964
up €35,964 (+25.6%), from €140,271 to €176,235
of which Other amounts receivable: +€22,472
- Deferred charges and accrued income +€33,877
up €33,877 (+350.1%), from €9,677 to €43,555
- Stocks and contracts -€14,448
down €14,448 (-7.8%), from €185,723 to €171,275
- Profit (loss) carried forward -€114,194
no longer reported in 2025 (was €114,194)
- Other debts -€92,587
down €92,587 (-30.3%), from €305,612 to €213,025
- Trade debts +€57,652
up €57,652 (+25.7%), from €224,393 to €282,045
- Tax, wage and social debts -€16,429
down €16,429 (-37.8%), from €43,476 to €27,047
of which Taxes: -€21,009
- Debts after one year -€16,205
down €16,205 (-11.3%), from €143,424 to €127,219
- Staff costs +€53,606
up €53,606 (+27.8%), from €192,990 to €246,597
- Taxes -€23,839
down €23,839 (-51.8%), from €45,994 to €22,155
- Gross operating margin -€18,172
down €18,172 (-4.3%), from €424,169 to €405,998
- Depreciation +€6,227
up €6,227 (+16.2%), from €38,468 to €44,696
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,102,736 | €915,541 | -€187,195 | -17.0% |
| Fixed assets | 21/28 | €229,854 | €279,119 | +€49,265 | +21.4% |
| Tangible fixed assets | 22/27 | €207,327 | €245,914 | +€38,587 | +18.6% |
| Land and buildings | 22 | €179,336 | €167,936 | -€11,401 | -6.4% |
| Plant, machinery and equipment | 23 | €2,105 | €13,189 | +€11,084 | +526.6% |
| Furniture and vehicles | 24 | €3,694 | €40,538 | +€36,844 | +997.4% |
| Other tangible fixed assets | 26 | €22,192 | €24,251 | +€2,059 | +9.3% |
| Financial fixed assets | 28 | €22,527 | €33,205 | +€10,678 | +47.4% |
| Current assets | 29/58 | €872,882 | €636,422 | -€236,459 | -27.1% |
| Stocks and contracts in progress | 3 | €185,723 | €171,275 | -€14,448 | -7.8% |
| Stocks | 30/36 | €185,723 | €171,275 | -€14,448 | -7.8% |
| Amounts receivable within one year | 40/41 | €140,271 | €176,235 | +€35,964 | +25.6% |
| Trade receivables | 40 | €123,841 | €137,333 | +€13,492 | +10.9% |
| Other amounts receivable | 41 | €16,430 | €38,902 | +€22,472 | +136.8% |
| Current investments | 50/53 | €50,000 | €50,000 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €487,211 | €195,358 | -€291,853 | -59.9% |
| Deferred charges and accrued income | 490/1 | €9,677 | €43,555 | +€33,877 | +350.1% |
| Total equity and liabilities | 10/49 | €1,102,736 | €915,541 | -€187,195 | -17.0% |
| Equity | 10/15 | €369,885 | €250,000 | -€119,885 | -32.4% |
| Contributions | 10/11 | €200,000 | €200,000 | = | 0.0% |
| Reserves | 13 | €55,691 | €50,000 | -€5,691 | -10.2% |
| Non-distributable reserves | 130/1 | €50,000 | €50,000 | = | 0.0% |
| Reserves not available under the articles | 1311 | €50,000 | €50,000 | = | 0.0% |
| Distributable reserves | 133 | €5,691 | - | -€5,691 | |
| Profit (loss) carried forward | 14 | €114,194 | - | -€114,194 | |
| Amounts payable | 17/49 | €732,851 | €665,541 | -€67,309 | -9.2% |
| Amounts payable after more than one year | 17 | €143,424 | €127,219 | -€16,205 | -11.3% |
| Financial debts | 170/4 | €143,424 | €127,219 | -€16,205 | -11.3% |
| Amounts payable within one year | 42/48 | €589,426 | €538,322 | -€51,104 | -8.7% |
| Current portion of amounts payable after more than one year | 42 | €15,945 | €16,205 | +€261 | +1.6% |
| Trade debts | 44 | €224,393 | €282,045 | +€57,652 | +25.7% |
| Suppliers | 440/4 | €224,393 | €282,045 | +€57,652 | +25.7% |
| Taxes, remuneration and social security | 45 | €43,476 | €27,047 | -€16,429 | -37.8% |
| Taxes | 450/3 | €21,009 | - | -€21,009 | |
| Remuneration and social security | 454/9 | €22,467 | €27,047 | +€4,580 | +20.4% |
| Other amounts payable | 47/48 | €305,612 | €213,025 | -€92,587 | -30.3% |
| Remuneration, social security and pensions | 62 | €192,990 | €246,597 | +€53,606 | +27.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €38,468 | €44,696 | +€6,227 | +16.2% |
| Other operating charges | 640/8 | €2,430 | €4,173 | +€1,743 | +71.7% |
| Gross operating margin | 9900 | €424,169 | €405,998 | -€18,172 | -4.3% |
| Operating profit (loss) | 9901 | €190,281 | €110,532 | -€79,748 | -41.9% |
| Financial income | 75/76B | €1,484 | €634 | -€849 | -57.2% |
| Recurring financial income | 75 | €1,484 | €634 | -€849 | -57.2% |
| Financial charges | 65/66B | €5,211 | €4,858 | -€353 | -6.8% |
| Recurring financial charges | 65 | €5,211 | €4,858 | -€353 | -6.8% |
| Profit (loss) for the period before taxes | 9903 | €186,553 | €106,309 | -€80,245 | -43.0% |
| Income taxes | 67/77 | €45,994 | €22,155 | -€23,839 | -51.8% |
| Profit (loss) for the period | 9904 | €140,559 | €84,153 | -€56,406 | -40.1% |
| Profit (loss) for the period to be appropriated | 9905 | €140,559 | €84,153 | -€56,406 | -40.1% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 28 September 2026 via checked.be.